Article
Mesenchymal stem cell treatment after neonatal hypoxic-ischemic brain injury improves behavioral outcome and induces neuronal and oligodendrocyte regeneration.
Brain, behavior, and immunity - 1 Mar 2010
van Velthoven Cindy T J, Kavelaars Annemieke, van Bel Frank, Heijnen Cobi J
Abstract excerpt
Birth asphyxia is a frequent cause of perinatal morbidity and mortality and treatment options are very limited. Our aim was to determine the effects of treatment with bone marrow-derived mesenchymal stem cells (MSC) after neonatal hypoxic-ischemic brain injury (HI). Nine-day old mice were exposed to cerebral HI and endogenous cell proliferation was determined by BrdU-incorporation. Maximal endogenous cell...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
